Helius Medical Technologies - Home

SIGNUP FOR NEWSLETTER

NASDAQ: HSDT

Call us: +1 877-564-0008

Menu

Stock Quote - HSDT

*Delayed quote courtesy of Google.

2022 News

List of articles in category 2022 News
Title Date
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022 10 Aug, 2022
Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering 05 Aug, 2022
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™ 12 Jul, 2022
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting 06 Jun, 2022
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS® 01 Jun, 2022
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference 31 May, 2022
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) 24 May, 2022
Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program 17 May, 2022
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS® 12 May, 2022
Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022 03 May, 2022
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS® 27 Apr, 2022
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability 26 Apr, 2022
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results 14 Mar, 2022
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 17 Feb, 2022
Helius Medical Technologies, Inc. Provides Corporate Update 26 Jan, 2022